AILEEN BAYS: Open Payments
NPI 1831526599 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 28 payments from 8 companies in 2025. Trend: 2023 $127 · 2024 $107 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $220 |
| ABBVIE INC. | 4 | $129 |
| Indivior Inc. | 4 | $88 |
| Alkermes, Inc. | 3 | $74 |
| Gilead Sciences, Inc. | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Braeburn Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: CAPLYTA, VRAYLAR, SUBLOCADE, VIVITROL, REXULTI, Epclusa, MAVYRET, BRIXADI.
Industry payments across IN — which companies pay providers there.
